Merel van Pieterson

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

M Jongsma, M Aardoom, Martinus A. Cozijnsen et al. · Gut · 2020 · 118 citations · Full text

Self-efficacy in adolescents with inflammatory bowel disease: A pilot study of the “IBD-yourself”, a disease-specific questionnaire

Marieke Zijlstra, Charlotte de Bie, Laura M. Breij et al. · Journal of Crohn s and Colitis · 2013 · 67 citations

Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial

Martinus A. Cozijnsen, Merel van Pieterson, Janneke N. Samsom et al. · BMJ Open Gastroenterology · 2016 · 33 citations · Full text

Serum Immune Profiling in Paediatric Crohn’s Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments

M Jongsma, L M M Costes, Irma Tindemans et al. · Journal of Crohn s and Colitis · 2023 · 17 citations · Full text

Validation and Reference Scores of the Transition Readiness Assessment Questionnaire in Adolescent and Young Adult IBD Patients

Martha A.C. van Gaalen, Emma van Gijn, Merel van Pieterson et al. · Journal of Pediatric Gastroenterology and Nutrition · 2023 · 12 citations